↓ Skip to main content

Opioids for neuropathic pain

Overview of attention for article published in Cochrane database of systematic reviews, August 2013
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news
5 news outlets
blogs
1 blog
policy
1 policy source
twitter
49 X users
facebook
1 Facebook page
wikipedia
6 Wikipedia pages
googleplus
1 Google+ user

Citations

dimensions_citation
263 Dimensions

Readers on

mendeley
427 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Opioids for neuropathic pain
Published in
Cochrane database of systematic reviews, August 2013
DOI 10.1002/14651858.cd006146.pub2
Pubmed ID
Authors

Ewan D McNicol, Ayelet Midbari, Elon Eisenberg

Abstract

This is an updated version of the original Cochrane review published in Issue 3, 2006, which included 23 trials. The use of opioids for neuropathic pain remains controversial. Studies have been small, have yielded equivocal results, and have not established the long-term profile of benefits and risks for people with neuropathic pain.

X Demographics

X Demographics

The data shown below were collected from the profiles of 49 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 427 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 <1%
Germany 1 <1%
United Kingdom 1 <1%
Australia 1 <1%
Spain 1 <1%
Iran, Islamic Republic of 1 <1%
Unknown 420 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 57 13%
Student > Master 55 13%
Student > Ph. D. Student 47 11%
Researcher 41 10%
Other 31 7%
Other 80 19%
Unknown 116 27%
Readers by discipline Count As %
Medicine and Dentistry 160 37%
Nursing and Health Professions 34 8%
Pharmacology, Toxicology and Pharmaceutical Science 25 6%
Psychology 17 4%
Neuroscience 13 3%
Other 49 11%
Unknown 129 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 82. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 February 2023.
All research outputs
#519,828
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#914
of 11,842 outputs
Outputs of similar age
#3,924
of 212,370 outputs
Outputs of similar age from Cochrane database of systematic reviews
#18
of 237 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,842 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.9. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 212,370 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 237 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.